Generalized anxiety disorder
Conditions
Interventions
None listed
Sponsors
Viatris Pharmaceuticals Japan Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Respondents must agree to participate in the research. 2.Respondents must be of age 18 or older at the time of expressing consent to participate in this study
Exclusion criteria
Exclusion criteria: There are no exclusion criteria for this study.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1.EQ-5D-5L scores in the population of GAD-7 scores 10 or higher vs. the rest, and differences in such scores between the two populations. 2.Status of medical institution visitations in the population of GAD-7 scores 10 or higher. 3.Status of disease recognition in the population of GAD-7 scores 10 or higher. | — |
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients of GAD-7 scores 10 or higher among the total population in this study. | — |
Countries
Japan
Contacts
Public ContactHaruhiko Seki
INTAGE Healthcare Marketing Insight Division Healthcare Research Department 1
Outcome results
None listed